• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜外新生血管形成的玻璃体中的内皮细胞刺激血管生成因子

Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.

作者信息

Taylor C M, Kissun R D, Schor A M, McLeod D, Garner A, Weiss J B

机构信息

Wolfson Angiogenesis Unit, Hope Hospital, Salford, England.

出版信息

Invest Ophthalmol Vis Sci. 1989 Oct;30(10):2174-8.

PMID:2477343
Abstract

The presence of endothelial cell-stimulating angiogenic factor (ESAF) in diseased human vitreous humour has been established. The molecular mass and chromatographic behavior of this material and its property of activating procollagenase indicate it to be identical to the ESAF isolated from other sources. The biological activity of ESAF from human vitreous was demonstrated by its ability to induce positive responses in the rabbit corneal pocket, and in the chick chorioallantoic membrane and yolk sac membrane tests.

摘要

已证实病变人类玻璃体液中存在内皮细胞刺激血管生成因子(ESAF)。该物质的分子量、色谱行为及其激活原胶原酶的特性表明它与从其他来源分离的ESAF相同。人玻璃体中ESAF的生物活性通过其在兔角膜囊、鸡绒毛尿囊膜和卵黄囊膜试验中诱导阳性反应的能力得以证明。

相似文献

1
Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.视网膜外新生血管形成的玻璃体中的内皮细胞刺激血管生成因子
Invest Ophthalmol Vis Sci. 1989 Oct;30(10):2174-8.
2
Increased procollagenase activating angiogenic factor in the vitreous humour of oxygen treated kittens.在接受氧气治疗的小猫的玻璃体液中,前胶原酶激活血管生成因子增加。
Br J Ophthalmol. 1988 Jan;72(1):2-4. doi: 10.1136/bjo.72.1.2.
3
Epiphyseal growth plate cartilage and chondrocytes in mineralising cultures produce a low molecular mass angiogenic procollagenase activator.
Bone Miner. 1987 Nov;3(2):143-58.
4
Chemical mediators of intraocular neovascularization.眼内新生血管形成的化学介质
Trans Ophthalmol Soc U K (1962). 1980 Sep;100(3):369-73.
5
Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.趋化因子,一种CX3C趋化因子,作为眼部血管生成的介质。
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5290-8. doi: 10.1167/iovs.07-0187.
6
Potentiating effect of heparin in the activation of procollagenase by a low-Mr angiogenesis factor.低分子量血管生成因子激活前胶原酶过程中肝素的增强作用。
FEBS Lett. 1983 Oct 31;163(1):62-5. doi: 10.1016/0014-5793(83)81163-6.
7
[Angiogenesis factor in intraocular tumors].[眼内肿瘤中的血管生成因子]
Rev Esp Oncol. 1982;29(3):413-21.
8
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.胎盘生长因子-1具有趋化性、促有丝分裂性和血管生成性。
Lab Invest. 1997 Apr;76(4):517-31.
9
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.内皮细胞中碱性成纤维细胞生长因子的过表达:一种血管生成和血管增殖性疾病的自分泌机制。
Cell Growth Differ. 1996 Feb;7(2):147-60.
10
Activation of a procollagenase by low-molecular-weight angiogenesis factor.
Biosci Rep. 1983 Feb;3(2):171-7. doi: 10.1007/BF01121948.

引用本文的文献

1
Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform.糖尿病视网膜病变中的血管生成-炎症相互作用:鸡胚尿囊膜/人玻璃体平台的新见解。
Front Immunol. 2020 Sep 29;11:581288. doi: 10.3389/fimmu.2020.581288. eCollection 2020.
2
A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage.慢性灰质半暗带、外侧微血管套叠和静脉性视束撕脱是糖尿病性玻璃体积血的基础。
Br J Ophthalmol. 2007 May;91(5):677-89. doi: 10.1136/bjo.2006.109199.
3
Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
增殖性糖尿病视网膜病变中的玻璃体内生长因子:与新生血管活性及血糖管理的相关性
Br J Ophthalmol. 1997 Mar;81(3):228-33. doi: 10.1136/bjo.81.3.228.
4
Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes.糖尿病和非糖尿病眼的玻璃体凝胶、后玻璃体下液和视网膜下液的生物学活性。
Br J Ophthalmol. 1992 Feb;76(2):79-83. doi: 10.1136/bjo.76.2.79.